Tailoring treatments for curable gastric cancer

British Journal of Surgery

Volumn 94, Issue 3, 2007, Pages 263-264

  Sano, T ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; EDITORIAL; ENDOSCOPY; GASTRECTOMY; GEOGRAPHIC DISTRIBUTION; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TREATMENT PLANNING;

HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 33947214093     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5785     Document Type: Editorial

References (6)

1. Sasako M, Sano T, Katai H, Maruyama K. Radical surgery. In: Gastric Cancer. Sugimura T, Sasako M, eds. Oxford University Press: Oxford, 1997; 223-248.
2. Soetikno R, Kaltenbach T, Yeh R, Gotoda T. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 2005; 23: 4490-4498.
3. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006; 7: 309-315.
4. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730.
5. Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A et al. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 2005; 92: 1103-1109.
6. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.